Coronavirus
WHO Considers Madagascar’s CVO Drink as Possible Treatment for COVID-19
WHO Considers Madagascar’s CVO Drink as Possible Treatment for COVID-19
World Health Organization (WHO) considers Madagascar’s CVO drink as a possible cure for Covid-19 after they stated that it welcomes innovations around the world including repurposing drugs, traditional medicines and developing new therapies in the search for potential treatments for COVID-19.
In a press release issued by the WHO on Monday evening which says;
“WHO recognizes that traditional, complementary and alternative medicine has many benefits and Africa has a long history of traditional medicine and practitioners that play an important role in providing care to populations. Medicinal plants such as Artemisia annua are being considered as possible treatments for COVID-19 and should be tested for efficacy and adverse side effects.
“Africans deserve to use medicines tested to the same standards as people in the rest of the world. Even if therapies are derived from traditional practice and natural, establishing their efficacy and safety through rigorous clinical trials is critical,” says WHO
However, Gistflash learnt that Madagascar is building a factory to mass-produce the drink from the extracts of the artimisia annua plant, which is used to treat malaria. The factory will be operational within a month, according to President Andry Rajoelina.
Madagascar President Distributes Plane Loads of Covid Organics (CVO) to 15 West African Countries.
“Our researchers and scientists are doing the necessary to make our coronavirus remedy a drug that meets the standards,” he said on state TV.
Madagascar’s herbal drink has also received a boost from other African countries. The president of Tanzania, John Magufuli, says he’s sending a plane to Madagascar to fetch the tonic, and Rajoelina said on Twitter that Equatorial Guinea’s vice minister for health had arrived in the country to procure an unknown quantity. Other countries that have shown interest are Senegal, Guinea-Bissau and Comoros.
African governments through their Ministers of Health adopted a resolution urging Member States to produce evidence on the safety, efficacy and quality of traditional medicine at the Fiftieth Session of the WHO Regional Committee for Africa in 2000.
Countries also agreed to undertake relevant research and require national medicines regulatory agencies to approve medicines in line with international standards, which include the product following a strict research protocol and undergoing tests and clinical trials. These studies normally involve hundreds of people under the monitoring of the national regulatory authorities and may take quite a few months in an expedited process.
WHO is working with research institutions to select traditional medicine products which can be investigated for clinical efficacy and safety for COVID-19 treatment. In addition, the Organization will continue to support countries as they explore the role of traditional health practitioners in prevention, control, and early detection of the virus as well as case referral to health facilities.
Over the past two decades, WHO has been working with countries to ensure safe and effective traditional medicine development in Africa by providing financial resources and technical support. WHO has supported clinical trials, leading 14 countries to issue marketing authorization for 89 traditional medicine products which have met international and national requirements for registration. Of these, 43 have been included in national essential medicines lists. These products are now part of the arsenal to treat patients with a wide range of diseases including malaria, opportunistic infections related to HIV, diabetes, sickle cell disease and hypertension. Almost all countries in the WHO African region have national traditional medicine policies, following support from WHO.
“As efforts are under way to find treatment for COVID-19, caution must be taken against misinformation, especially on social media, about the effectiveness of certain remedies. Many plants and substances are being proposed without the minimum requirements and evidence of quality, safety and efficacy. The use of products to treat COVID-19, which have not been robustly investigated can put people in danger, giving a false sense of security and distracting them from hand washing and physical distancing which are cardinal in COVID-19 prevention, and may also increase self-medication and the risk to patient safety.
WHO welcomes every opportunity to collaborate with countries and researchers to develop new therapies and encourages such collaboration for the development of effective and safe therapies for Africa and the world.
Coronavirus
COVID-19 Quarantine: 18% in-bound passengers not traceable — Sanwo-Olu
Coronavirus
COVID-19 taskforce uncovers Delta variant in Oyo State
Coronavirus
NCDC confirms deadly Delta variant of COVID-19 in Nigeria
- CBN Sells Polaris Bank To SCIL
Spread the loveThe Central Bank of Nigeria (CBN) has announced the completion of the sale of shares in Polaris Bank to Strategic Capital Investment Limited (SCIL), a new core investor. In a statement signed by its Director, Corporate Communications […] - “No Way Back For You In Man United Squad, Spoilt Brat” – Darren Bent Slams Ronaldo
Spread the loveDarren Bent, a former Charlton, Tottenham and Sunderland striker, has suggested that the end of Cristiano Ronaldo has come at Manchester United. The former England man said he sees no way the former Real Madrid star can […] - Gunmen Attack Anambra Police Station, Kill Four Officers
Spread the loveUnknown gunmen in the early hours of Wednesday attacked a police station located in Atani, the headquarters of Ogbaru Local Government Area of Anambra State. It was gathered that the gunmen launched the attack on the police […] - Supreme Court Affirms Six-Year Jail Term For Former Director Of Pensions, John Yakubu
Supreme Court Affirms Six-Year Jail Term For Former Director Of Pensions, John Yakub The Supreme Court has affirmed the six years imprisonment imposed on a former Federal Director of Pensions, Mister John Yakubu, and also ordered him to refund […] - Media Intelligence agency Marks Six years of Operation in Nigeria
Spread the loveMedia Intelligence agency Marks Six years of Operation in Nigeria. P+ Measurement Services, Nigeria’s foremost Independent Public Relations measurement and evaluation agency, celebrates its sixth year of effective operation with qualitative offerings for its numerous clients, as it […]
Pingback: Plant Extract in Madagascar’s CVO Drink ‘Artemisia Annua’ Grows in Nigeria – Minister of Health, Osagie Ehanire. - Chinonyerem Emmanuella's Blog (GistFlash)